Clinical Cancer Research CR Balducci Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 13, 3490, June 15, 2007. doi: 10.1158/1078-0432.CCR-07-0402
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaijzel, E. L.
Right arrow Articles by Löwik, C. W.G.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaijzel, E. L.
Right arrow Articles by Löwik, C. W.G.M.
Related Collections
Right arrow Tumor Biology
Right arrow Tumor Biology: Model Organisms and Imaging

CCR Focus

Whole-Body Optical Imaging in Animal Models to Assess Cancer Development and Progression

Eric L. Kaijzel1, Gabri van der Pluijm1,2 and Clemens W.G.M. Löwik1

Authors' Affiliations: 1 Departments of Endocrinology and Metabolic Diseases and 2 Urology, Leiden University Medical Center, Leiden, the Netherlands

Requests for reprints: Clemens W.G.M. Löwik, Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. Phone: 31-71-5263075 or 5262490; Fax: 31-71-5248136; E-mail: c.w.g.m.lowik{at}lumc.nl.

Abstract

Different optical-based imaging models were used to investigate tumor progression and metastasis with particular emphasis on metastasis to bone and bone marrow. We describe how optical imaging can be used to follow important processes in tumor development and treatment response, including angiogenesis, apoptosis, and proteolysis. Finally, we discuss the translation of one optical imaging modality, near-IR fluorescence, from animal validation studies to applications in the clinic related to cancer management.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
C. Zhang, Z. Yan, M. E. Arango, C. L. Painter, and K. Anderes
Advancing Bioluminescence Imaging Technology for the Evaluation of Anticancer Agents in the MDA-MB-435-HAL-Luc Mammary Fat Pad and Subrenal Capsule Tumor Models
Clin. Cancer Res., January 1, 2009; 15(1): 238 - 246.
[Abstract] [Full Text] [PDF]


Home page
CRO ContentHome page
G. C. Prendergast
Non-Invasive Imaging: Enhancing Preclinical Research and Evidence-Based Medicine
Cancer Reviews Online Content, July 1, 2007; 2007(4): 7 - 7.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. G. Blasberg
Imaging Update: New Windows, New Views
Clin. Cancer Res., June 15, 2007; 13(12): 3444 - 3448.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.